Cumulative recurrence after surgical resection for hepatocellular carcinoma (HCC) is very high. Several retrospective analyses have shown that liver transplantation was more effective than resection for patients with HCC at early tumor stages. Consequently, in January 1990, we decided to prospective
Isolated perfused cirrhotic human liver obtained from liver transplant patients: A feasibility study
✍ Scribed by Dr. Jean-Pierre Villeneuve; P.-Michel Huet; Louise Gariepy; Daphna Fenyves; Bernard Willems; Jean Cǒté; Réal Lapointe; Denis Marleau
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 575 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Cirrhotic livers obtained from eight patients who underwent orthotopic liver transplantation were perfused through the portal vein and hepatic artery in a closed recycling system for periods ranging from 2 to 7 hr. An average perfusion flow of 461 ml/min was used, with about 80% coming from the portal vein and 20% from the hepatic artery. The livers appeared to remain viable as BB8888ed by gross appearance, stable portal vein and hepatic artery pressures, oxygen consumption and bile production. The extraction ratio of indocyanine green by the perfused livers averaged 0.098 (range = 0.023 to 0.168); that of propranolol averaged 0.446 (range = 0.126 to 0.813). Using the multipleindicator dilution-curve method, shunts >16 km in diameter were demonstrated between the portal and hepatic veins in six of eight cases, whereas shunts from the hepatic artery to the hepatic veins were absent. Perfusion of human livers obtained during hepatic transplantation is a fairly simple procedure that w i l l allow reaearchers to gain new insighb into cirrhosis in humans. (&PATOLOW 1990;12:267-263.)
📜 SIMILAR VOLUMES
Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients